Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway
Bo Peng, Rong He, Qihua Xu, et al.
Pharmacological Research (2019) Vol. 142, pp. 1-13
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy
Hanbing Liu, Xiaoyan Lu, Yang Hu, et al.
Pharmacological Research (2020) Vol. 161, pp. 105263-105263
Open Access | Times Cited: 249
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Zimei Yang, Qiuhua Zhang, Linghong Yu, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113249-113249
Closed Access | Times Cited: 163
Expression and clinical significance of MAPK and EGFR in triple‑negative breast cancer
Weihua Jiang, Xiaowen Wang, Zhang Chen-guang, et al.
Oncology Letters (2020)
Open Access | Times Cited: 71
Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight
Rutuja Damare, Kritika Engle, Gautam Kumar
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2406-2447
Closed Access | Times Cited: 10
Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities
Li Yang, Hecun Zou, Yongchao Gao, et al.
Drug Metabolism Reviews (2020) Vol. 52, Iss. 1, pp. 125-138
Closed Access | Times Cited: 55
Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification
Mingying Wang, Haonan Li, Weiwei Liu, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112087-112087
Closed Access | Times Cited: 53
lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
Shujun Zhang, Juan Li, Huiru Gao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 51
Graphene-modified CePO4 nanorods effectively treat breast cancer-induced bone metastases and regulate macrophage polarization to improve osteo-inductive ability
Yu‐Wei Ge, Xiaoliang Liu, Degang Yu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Macrophage-Mimic Hollow Mesoporous Fe-Based Nanocatalysts for Self-Amplified Chemodynamic Therapy and Metastasis Inhibition via Tumor Microenvironment Remodeling
Wenbao Zuo, Weibin Chen, Jinxue Liu, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 4, pp. 5053-5065
Closed Access | Times Cited: 33
Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State
Hyunju Kang, Bohkyung Kim
Foods (2023) Vol. 12, Iss. 5, pp. 925-925
Open Access | Times Cited: 18
Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6/JAK2/STAT3 pathway
Rumeng Ding, Quancheng Kan, Ting Wang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Effects and mechanisms of dietary bioactive compounds on breast cancer prevention
Kumar Ganesan, Bing Du, Jianping Chen
Pharmacological Research (2021) Vol. 178, pp. 105974-105974
Closed Access | Times Cited: 38
Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells
Yujin Jin, Diem Thi Ngoc Huynh, Chang‐Seon Myung, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10458-10458
Open Access | Times Cited: 36
Therapeutic effects of ginsenosides on breast cancer growth and metastasis
Yujin Jin, Diem Thi Ngoc Huynh, Thuy Le Lam Nguyen, et al.
Archives of Pharmacal Research (2020) Vol. 43, Iss. 8, pp. 773-787
Closed Access | Times Cited: 32
Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1205-1205
Open Access | Times Cited: 29
A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
Muhammad Naeem, Muhammad Omer Iqbal, Humaira Khan, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3412-3412
Open Access | Times Cited: 18
Thidiazuron decreases epithelial‐mesenchymal transition activity through the NF‐kB and PI3K/AKT signalling pathways in breast cancer
Peramaiyan Rajendran, Rebaï Ben Ammar, Fatma J. Al‐Saeedi, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 24, pp. 14525-14538
Open Access | Times Cited: 22
The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition
El‐Shaimaa A. Arafa, Mohamed S. Refaey, Omnia A. M. Abd El‐Ghafar, et al.
Heliyon (2021) Vol. 7, Iss. 11, pp. e08354-e08354
Open Access | Times Cited: 18
Prevention and treatment of natural products from Traditional Chinese Medicine in depression: Potential targets and mechanisms of action
Ming‐Chao He, Rui Feng, Jing Wang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 12
EGFR-Targeted Liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative Breast Cancer Growth and Metastasis
Haiyan Gu, Rui Shi, Xu Chen, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 1157-1165
Closed Access | Times Cited: 7
Correction to: Graphene-modified CePO4 nanorods effectively treat breast cancer-induced bone metastases and regulate macrophage polarization to improve osteo-inductive ability
Yu‐Wei Ge, Xiaoliang Liu, Degang Yu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Inhibitory activities of 20(R, S)-protopanaxatriol against epidermal growth factor receptor tyrosine kinase
Jingqi Zhao, Tiehua Zhang, Yuan Liang, et al.
Food and Chemical Toxicology (2021) Vol. 155, pp. 112411-112411
Closed Access | Times Cited: 17
The anti-tumor efficacy of 20(S)-protopanaxadiol, an active metabolite of ginseng, according to fasting on hepatocellular carcinoma
Wenzhen Li, Yifan Wang, Xinbo Zhou, et al.
Journal of Ginseng Research (2021) Vol. 46, Iss. 1, pp. 167-174
Open Access | Times Cited: 15
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer
Ruiyuan Jiang, Ziru Fang, Huanping Zhang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
A Review: Mechanism of Phyllanthus urinaria in Cancers—NF-κB, P13K/AKT, and MAPKs Signaling Activation
Roland Osei Saahene, Elvis Agbo, Precious Barnes, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top